Medical management of the failing Fontan. Pediatr Cardiol 2007;28(6):465-71
Date
09/04/2007Pubmed ID
17763892DOI
10.1007/s00246-007-9007-0Scopus ID
2-s2.0-36349026438 (requires institutional sign-in at Scopus site) 89 CitationsAbstract
The Fontan operation accomplishes complete separation of systemic venous blood from pulmonary venous circulation in patients with single ventricle anatomy. Operative survival since the first description of the Fontan operation is excellent in the current era through modifications in surgical techniques, identification of patient-specific risk factors, and advances in postoperative care. Improved early outcomes have also resulted in a decline in late mortality for patients who have undergone staged palliation with the Fontan operation. As the number of late survivors from the Fontan operation increases, caregivers will be evermore faced with the challenge of recognizing and managing the patient with failing Fontan physiology. Even after excellent early results, patients with single ventricle lesions remain at risk of progressive ventricular dysfunction, dysrhythmias, progressive hypoxemia, elevated pulmonary vascular resistance, and protein-losing enteropathy, which can result in morbidities including but not limited to, myocardial failure, thromboembolism, and stroke. Consequently, continued long-term survival of patients who undergo the Fontan operation is dependent upon preservation of single ventricle function, avoidance of late complications, and, in the patient with a failing Fontan, recognition and treatment of the underlying pathophysiologic process that has resulted in Fontan failure.
Author List
Ghanayem NS, Berger S, Tweddell JSMESH terms used to index this publication - Major topics in bold
Fontan ProcedureHeart Defects, Congenital
Humans
Hypoxia
Incidence
Lung Diseases
Protein-Losing Enteropathies
Risk Factors
Treatment Failure
Vascular Resistance
Ventricular Dysfunction









